Pulmonary Cell News Volume 12.42 | Oct 26 2023

    0
    10







    2023-10-25 | IIDN 11.42








    2023-10-26 | PULCN 12.42


    Immunology of Infectious Disease News by STEMCELL Technologies
    Vol. 11.42 – 25 October, 2023
    TOP STORY

    Red Blood Cell-Derived Extracellular Vesicles Display Endogenous Antiviral Effects and Enhance the Efficacy of Antiviral Oligonucleotide Therapy

    Scientists demonstrated that unmodified red blood cell-derived extracellular vesicles could inhibit SARS-CoV-2 infection in a phosphatidylserine-dependent manner.
    [ACS Nano]

    Full ArticleGraphical Abstract
    PneumaCult for primary airway epithelial cell culture at the air-liquid interface or as airway organoid.
    PUBLICATIONSRanked by the impact factor of the journal

    Activation of Coagulation and Proinflammatory Pathways in Thrombosis with Thrombocytopenia Syndrome and Following COVID-19 Vaccination

    Researchers utilized transcriptomic and proteomic profiling to compare individuals who received two doses of Ad26.COV2.S with those vaccinated with BNT162b2 or mRNA-1273.
    [Nature Communications]

    Full Article

    Design, Structure, and Plasma Binding of Ancestral β-CoV Scaffold Antigens

    Investigators reported the application of ancestral sequence reconstruction on coronavirus spike protein, resulting in stable and highly soluble ancestral scaffold antigens.
    [Nature Communications]

    Full Article

    Body Composition and Cardiorespiratory Fitness of Overweight COVID-19 Survivors in Different Severity Degrees: A Cohort Study

    This prospective cohort aimed to assess body composition, cardiopulmonary fitness, and long-term symptoms of overweight individuals affected by COVID-19. Participants were divided into three groups according to the severity of acute COVID-19: mild, moderate, and severe/critical cases.
    [Scientific Reports]

    Full ArticlePress Release

    Over-Representation Analysis of Angiogenic Factors in Immunosuppressive Mechanisms in Neoplasms and Neurological Conditions during COVID-19

    Researchers identified biological processes and pathways involved in various diseases which were most likely affected by COVID-19.
    [Microbial Pathogenesis]

    AbstractGraphical Abstract

    CD8+ Lymphocytes Are Critical for Early Control of Tuberculosis in Macaques

    Researchers depleted innate and/or adaptive CD8+ lymphocytes in macaques and showed that loss of all CD8α+ cells significantly impaired early control of Mycobacterium tuberculosis infection, leading to increased granulomas, lung inflammation, and bacterial burden.
    [Journal Of Experimental Medicine]

    Abstract

    IL-27 Produced during Acute Malaria Infection Regulates Plasmodium-Specific Memory CD4+ T Cells

    Researchers identified a critical window of CD4+ T cell responses that were targeted by IL-27. Neutralization of IL-27 during acute infection with Plasmodium chabaudi expanded specific CD4+ T cells, which were maintained at high levels thereafter.
    [EMBO Molecular Medicine]

    Full ArticleGraphical Abstract

    The Interaction of Human Immunodeficiency Virus-1 and Human Endogenous Retroviruses in Patients (Primary Cell Cultures) and Cell Line Models

    Scientists studied the differential expression of multiple human endogenous retroviruses (HERVs) families in the presence of HIV infection in the peripheral blood mononuclear cells of HIV-positive individuals, in HIV-infected cell lines, and in vitro HIV-infected macrophages/monocytes of healthy donors.
    [Microbiology Spectrum]

    Full Article

    Combined Effect of the Pro-Apoptotic rhTRAIL Protein and HSV-1 Virus in Head and Neck Cancer Cell Lines

    Investigators evaluated the combined effect of the pro-apoptotic protein rhTRAIL with the replication-competent wild-type HSV-1 virus in head and neck cancer cell lines.
    [Scientific Reports]

    Full Article
    Easy250 EasySep Magnet for rapid immune cell isolation from large-volume samples.
    REVIEWS

    The Role of SARS-CoV-2-Mediated NF-κB Activation in COVID-19 Patients

    Scientists summarize the role of NF-κB activation during SARS-CoV-2 invasion and replication, particularly the angiotensin-converting enzyme 2-mediated NF-κB activation.
    [Hypertension Research]

    Full ArticleGraphical Abstract

    Strategies for Hepatitis B Virus Prevention in People Living with HIV

    The authors review strategies in hepatitis B virus (HBV) prevention among people living with HIV, focusing specifically on updates in HBV vaccination and chemoprophylaxis.
    [Current HIV/Aids Reports]

    Abstract
    INDUSTRY AND POLICY NEWS

    Billions Boost Next-Generation COVID-19 Vaccine and Treatments

    Six months after announcing the $5 billion Project NextGen to develop treatments and vaccines that can “stay ahead of COVID-19,” the US government has awarded 20 contracts that reveal what much of that sum will support.
    [Science]

    Press Release

    Anti-COVID Drug Accelerates Viral Evolution

    Molnupiravir, an antiviral drug used to treat COVID-19, induces numerous mutations in the SARS-CoV-2 genome that can increase the rate at which the virus evolves — yielding viral variants that might survive and be passed on.
    [Nature]

    Press Release
    FEATURED EVENT

    Donor Selection & Cell Source Summit

    November 28 – 30, 2023
    San Francisco, California, United States

    > See All Events

    JOB OPPORTUNITIES

    Lab Coordinator – Infectious Disease

    University of Minnesota Twin Cities – Minneapolis, Minnesota, United States

    Postdoctoral Position – Post-COVID and COPD Bioinformatics

    Karolinska Institutet – Solna, Sweden

    Research Associate – Department of Infectious Diseases

    King’s College London – Harrow, England, United Kingdom

    Assistant/Associate Professor – Infectious Disease

    Medical College of Wisconsin – Milwaukee, Wisconsin, United States

    Researcher Opportunities – Pediatrics Infectious Diseases

    University of Washington – Medical Lake, Washington, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Immunology of Infectious Disease News Twitter

    Pulmonary Cell News by STEMCELL Technologies
    Vol. 12.42 – 26 October, 2023
    TOP STORY

    Sohlh2 Promotes Pulmonary Fibrosis via Repression of p62/Keap1/Nrf2 Mediated Anti-Oxidative Signaling Pathway

    Using a type II alveolar epithelial cell-specific Sohlh2 conditional knock-in mouse model, researchers found that Sohlh2, a basic HLH transcription factor, accelerated age-related pulmonary fibrosis.
    [Cell Death & Disease]

    Full Article
    An informative, visually-compelling wallchart detailing the organization and biology of the respiratory system. Request your copy.
    PUBLICATIONSRanked by the impact factor of the journal

    Cellular Senescence Contributes to the Progression of Hyperoxic Bronchopulmonary Dysplasia

    Cellular senescence increased in rat and human bronchopulmonary dysplasia lungs, as evidenced by increased oxidative DNA damage, tumor suppressors, GL-13 stain, and inflammatory cytokines with decreased cell proliferation and lamin B expression.
    [American Journal Of Respiratory Cell And Molecular Biology]

    Abstract

    Agonists and Hydrogen Peroxide Mediate Hyperoxidation of β2-Adrenergic Receptor in Airway Epithelial Cells: Implications for Tachyphylaxis to β2-Agonists in Constrictive Airway Disorders

    Using airway epithelial cell lines and primary small airway epithelial cells from healthy and asthma-diseased donors, investigators showed that β2AR agonism generated H2O2 in a receptor and NAPDH oxidase-dependent manner.
    [Biomedicine & Pharmacotherapy]

    Full Article

    ZC3H4 Governs Epithelial Cell Migration through ROCK/P-PYK2/P-MLC2 Pathway in Silica-Induced Pulmonary Fibrosis

    Scientists explored the mechanisms of ZC3H4 by which to stimulate epithelial cell migration. Pathological analysis and 2D migration assay were established to uncover the pulmonary fibrotic lesions and epithelial cell migration, respectively.
    [Environmental Toxicology And Pharmacology]

    Abstract

    Mesenchymal Stem Cells Ameliorate H9N2-Induced Acute Lung Injury by Inhibiting Caspase-3-GSDME-Mediated Pyroptosis of Lung Alveolar Epithelial Cells

    Researchers demonstrated that bone marrow-derived mesenchymal stem cells prevented and ameliorated acute lung injury by inhibiting Caspase-3-GSDME-mediated pyroptosis of lung epithelial cells as well as hypercytokinemia.
    [European Journal Of Pharmacology]

    Full Article

    Cancer-Associated Fibroblasts in Early-Stage Lung Adenocarcinoma Correlate with Tumor Aggressiveness

    Investigators analyzed tissue samples isolated from patients with lung adenocarcinoma (LUAD) at early stages and used imaging-based biomarkers to predict LUAD behavior.
    [Scientific Reports]

    Full Article

    IL-18 Serves as a Main Effector of CAF-Derived METTL3 Against Immunosuppression of NSCLC via Driving NF-κB Pathway

    Researchers explored whether methyltransferase like 3 (METTL3) in cancer associated fibroblasts (CAFs) affected the secretion of IL-18, which drove NSCLC cells to regulate PD-L1-mediated immunosuppression via the nuclear factor kappa B (NF-κB) pathway.
    [Epigenetics]

    Full Article

    UPK1B Promoted the Invasion and Stem Cell Characteristics of Non-Small Cell Lung Cancer Cells by Modulating C-myc/Sox4 Axis

    Uroplakin1B (UPK1B) was overexpressed or knocked down in the NSCLCs were. The proliferation and invasion of those cells were detected with the EdU staining and transwell assays.
    [Tissue And Cell]

    Abstract

    Comparison of Cell Viability Methods for Human Mesenchymal/Stromal Stem Cells and Human A549 Lung Carcinoma Cells after Freeze-Thaw Stress

    Investigators assessed commonly used viability assays in clinically relevant human mesenchymal/stromal stem cells and human A549 lung carcinoma cells.
    [Journal Of Pharmacological And Toxicological Methods]

    Abstract
    Your Online Resource for Cell Visualization. View StainsFile.
    REVIEWS

    Novel Therapeutic Options for Small Cell Lung Cancer

    The authors focus on the recent advances in the molecular knowledge of SCLC and potential promising new treatment strategies, like targeting the DNA damage pathway, epigenetics, angiogenesis, and oncogenic drivers.
    [Current Oncology Reports]

    Full Article
    INDUSTRY AND POLICY NEWS

    Bolt Biotherapeutics Announces First Patient Dosed in Phase I/II Study of BDC-3042 in Patients with Advanced Cancers

    Bolt Biotherapeutics announced that the first patient has been dosed with BDC-3042 in the single-agent dose-escalation portion of this first-in-human Phase I/II clinical study. They evaluated BDC-3042 in patients with metastatic or unresectable cancers including triple-negative breast cancer, colorectal cancer, NSCLC.
    [Bolt Biotherapeutics]

    Press Release

    Roche’s Alecensa Reduces the Risk of Disease Recurrence or Death by an Unprecedented 76% in People with ALK-Positive Early-Stage Non-Small Cell Lung Cancer

    The study results showed that Alecensa® reduced the risk of disease recurrence or death by 76% compared with platinum-based chemotherapy in people with completely resected stage IB to IIIA ALK-positive NSCLC.
    [Roche]

    Press Release
    FEATURED EVENT

    Donor Selection & Cell Source Summit

    November 28 – 30, 2023
    San Francisco, California, United States

    > See All Events

    JOB OPPORTUNITIES

    Pulmonary Physician – Lung Transplant/ Advanced Lung Disease

    University of Wisconsin-Madison – Madison, Wisconsin, United States

    Postdoctoral Position – Post-COVID and COPD Bioinformatics

    Karolinska Institutet – Solna, Sweden

    Postdoctoral Fellow – Medicine and Genetics

    Yale University – New Haven, Connecticut, United States

    Researcher – Cystic Fibrosis

    University of Alabama at Biringham – Birmingham, Alabama, United States

    Faculty Positions – Cancer Research

    University of Alabama at Birmingham – Birmingham, Alabama, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Pulmonary Cell News Twitter